研究者業績

藤沢 治樹

fujisawa haruki

基本情報

所属
藤田医科大学 医学部 内分泌・代謝・糖尿病内科学
学位
医学博士(名古屋大学)

J-GLOBAL ID
201801006704331319
researchmap会員ID
7000023604

論文

 59
  • Yukino Shoji, Yuki Naruse, Naoko Iwata, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura, Masato Mori, Ryugo Hiramoto
    Journal of clinical research in pediatric endocrinology 2023年9月25日  
    Childhood-onset lymphocytic infundibuloneurohypophysitis (LINH) has rarely been reported. Pathological evaluation via pituitary biopsy is necessary for a definitive diagnosis of LINH. However, pituitary biopsy is a highly invasive procedure. Recently, anti-rabphilin-3A antibody (RPH3A-Ab) has been reported as a promising diagnostic marker for LINH in adults; however, there are few such reports in the pediatric population. We report the case of an 8-year-old boy with central diabetes insipidus (CDI) who was clinically diagnosed with LINH based on RPH3A-Ab positivity. He was diagnosed with CDI using a water deprivation test combined with desmopressin administration. Serum and cerebrospinal fluid tumor markers were negative, and T1-weighted magnetic resonance imaging (MRI) revealed the absence of high signal intensity in the posterior pituitary gland and an enlarged pituitary stalk. Anterior pituitary function tests revealed no abnormalities. No pituitary biopsy was performed because of its invasive nature, and desmopressin treatment was initiated. Three months after CDI onset, the patient tested positive for RPH3A-Ab. MRI performed 9 months after CDI onset revealed amelioration of the pituitary stalk enlargement, and the clinical course corroborated our diagnosis of LINH. RPH3A-Ab may be useful as an early diagnostic tool for LINH in the pediatric population.
  • Haruki Fujisawa, Takako Takeuchi, Akira Ishii, Jun Muto, Hotaka Kamasaki, Atsushi Suzuki, Yoshihisa Sugimura
    Hormones (Athens, Greece) 2023年9月11日  
    BACKGROUND: Central diabetes insipidus (CDI) is a rare condition caused by various underlying diseases, including neoplasms, autoimmune diseases, and infiltrative diseases. Differentiating between CDI etiologies is difficult. What has initially been classified as "idiopathic" central diabetes insipidus might in fact underlie various pathogenic mechanisms that are less understood to date and/or are not obvious at initial presentation. Therefore, even if idiopathic CDI is diagnosed at the time of onset, it is common for tumors such as germinoma to develop during surveillance. Crucially, a delayed diagnosis of germinoma may be associated with a worse prognosis. Recently, the presence of anti-rabphilin-3A antibodies has been found to be a highly sensitive and specific marker of lymphocytic infundibuloneurohypophysitis, an autoimmune-mediated CDI. CASE PRESENTATION: We herein present two cases, namely, a 13-year-old boy (patient 1) and a 19-year-old young man (patient 2) who were diagnosed with idiopathic CDI. In both patients, panhypopituitarism developed. Magnetic resonance imaging revealed pituitary stalk thickening and pituitary swelling approximately 1 1/2 years after the onset of CDI. Western blotting did not reveal the presence of anti-rabphilin-3A antibodies in serum in either patient, suggesting that autoimmune mechanisms might not be involved. Both patients were subsequently diagnosed with germinoma on pathological examination. They received chemotherapy, followed by radiation therapy. Notably, testosterone and insulin-like growth factor-1 levels normalized, and libido and beard growth recovered after chemoradiotherapy in patient 2. CONCLUSION: Our data suggest that the absence of anti-rabphilin-3A antibodies in young patients clinically diagnosed with idiopathic CDI may increase the probability of the development of non-lymphocytic lesions, including germinoma. We thus recommend a more attentive approach at the onset of these diseases.
  • Atsuki Ohashi, Yuri Takeda, Mizuki Watada, Fumitaka Ihara, Tadashi Oshita, Naoko Iwata, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura, Yoshitaka Maeda
    CEN case reports 12(3) 297-303 2023年8月  
    A 36-year-old female was pointed out to have liver enzyme elevation by routine health checkup. Subsequent contrast-enhanced CT scan identified gigantic uterine fibroids and retroperitoneal tumor. She was referred to the gynecologist at JA Toride Medical Center and planned to undergo a uterus enucleation and biopsy of the retroperitoneal tumor. The surgery was conducted without any troubles. After the surgery, the patient presented polyuria with urine volume 10-20 L a day and developed hypovolemic shock. Laboratory test revealed hypotonic urine and hypernatremia. Arginine vasopressin (AVP) loading test suggested shortage of endogenous vasopressin. Since the subcutaneous administration of AVP was not sufficient to control the urine volume, continuous intravenous infusion of AVP was initiated. After achieving hemodynamic stability, the treatment was switched to oral desmopressin. MRI finding indicated attenuation of high signal in posterior pituitary in T1 weighted image while neither enlargement of pituitary nor thickening of pituitary stalk was indicated by enhanced MRI. Hypertonic salt solution test indicated no responsive elevation of AVP, confirming the diagnosis of central diabetes insipidus (CDI). Her anterior pituitary function was preserved. Only anti-rabphilin-3A antibody was found positive in the serum of the patient, while other secondary causes for CDI were denied serologically and radiologically. Hence, lymphocytic infundibuloneurohypophysitis (LINH) was suspected as the final diagnosis. Hormonal replacement therapy by nasal desmopressin was continued and the patient managed to control her urine volume. In cases of CDI considered idiopathic with conventional examinations, anti-rabphilin-3A antibody may be a clue for determining the cause as LINH.
  • Shinji Ueno, Yusuke Seino, Shihomi Hidaka, Masashi Nakatani, Keisuke Hitachi, Naoya Murao, Yasuhiro Maeda, Haruki Fujisawa, Megumi Shibata, Takeshi Takayanagi, Katsumi Iizuka, Daisuke Yabe, Yoshihisa Sugimura, Kunihiro Tsuchida, Yoshitaka Hayashi, Atsushi Suzuki
    Journal of diabetes investigation 2023年6月9日  
    AIMS/INTRODUCTION: Glucagon is secreted from pancreatic α-cells and plays an important role in amino acid metabolism in liver. Various animal models deficient in glucagon action show hyper-amino acidemia and α-cell hyperplasia, indicating that glucagon contributes to feedback regulation between the liver and the α-cells. In addition, both insulin and various amino acids, including branched-chain amino acids and alanine, participate in protein synthesis in skeletal muscle. However, the effect of hyperaminoacidemia on skeletal muscle has not been investigated. In the present study, we examined the effect of blockade of glucagon action on skeletal muscle using mice deficient in proglucagon-derived peptides (GCGKO mice). MATERIALS AND METHODS: Muscles isolated from GCGKO and control mice were analyzed for their morphology, gene expression and metabolites. RESULTS: GCGKO mice showed muscle fiber hypertrophy, and a decreased ratio of type IIA and an increased ratio of type IIB fibers in the tibialis anterior. The expression levels of myosin heavy chain (Myh) 7, 2, 1 and myoglobin messenger ribonucleic acid were significantly lower in GCGKO mice than those in control mice in the tibialis anterior. GCGKO mice showed a significantly higher concentration of arginine, asparagine, serine and threonine in the quadriceps femoris muscles, and also alanine, aspartic acid, cysteine, glutamine, glycine and lysine, as well as four amino acids in gastrocnemius muscles. CONCLUSIONS: These results show that hyperaminoacidemia induced by blockade of glucagon action in mice increases skeletal muscle weight and stimulates slow-to-fast transition in type II fibers of skeletal muscle, mimicking the phenotype of a high-protein diet.
  • 藤沢 治樹, 渡辺 崇, 竹内 英之, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 99(1) 297-297 2023年5月  
  • 森嶌 早紀, 岩崎 文菜, 綿引 基, 林 千雅, 柏原 裕美子, 佐々木 茂和, 大村 晋一郎, 藤沢 治樹, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 99(1) 354-354 2023年5月  
  • 藤沢 治樹, 椙村 益久
    糖尿病・内分泌代謝科 56(5) 563-567 2023年5月  
  • 高橋 明広, 亀田 啓, 古澤 翔, 宮 愛香, 野本 博司, 曹 圭龍, 中村 昭伸, 岩田 尚子, 藤沢 治樹, 鈴木 敦詞, 椙村 益久, 三好 秀明, 渥美 達也
    日本内分泌学会雑誌 99(Suppl.Update) 11-13 2023年5月  
  • An Murai, Naoki Shinojima, Genki Ikuta, Kazutaka Ozono, Yutaka Ueda, Hiroyo Mabe, Kenji Nakamura, Naoko Iwata, Haruki Fujisawa, Fusa Nagamatsu, Nagisa Komatsu, Ken Uekawa, Shigeyuki Nishikawa, Kimitoshi Nakamura, Yoshiki Mikami, Atsushi Suzuki, Yoshihisa Sugimura, Akitake Mukasa
    Endocrine journal 70(7) 703-709 2023年4月13日  
    Lymphocytic hypophysitis (LYH) is a rare chronic inflammatory disease characterized by lymphocytic infiltration of the anterior or posterior pituitary gland and hypothalamus. LYH is subdivided into lymphocytic adenohypophysitis (LAH), lymphocytic infundibulo-neurohypophysitis (LINH), and lymphocytic panhypophysitis (LPH) depending on the primary site. Most cases occur in adults, with few cases reported in children, and it is especially important to distinguish LYH from suprasellar malignancies, such as germ cell tumors and other neoplastic diseases. Although a biopsy is necessary for definitive diagnosis, it is desirable to be able to diagnose the disease without biopsy if possible, especially in children, because of the surgical invasiveness of the procedure. Recently, serum anti-rabphilin-3A antibodies have attracted attention as diagnostic markers for LYH, especially in LINH, but there are only a few reports on pediatric patients. In the present study, we experienced two children with LPH and LAH, respectively, who tested positive for anti-rabphilin-3A antibodies. This is the first report of children with LYH other than LINH positive for anti-rabphilin-3A antibodies, and anti-rabphilin-3A antibodies may be a useful non-invasive diagnostic marker not only for LINH but also for LYH in general. We also discuss the sensitivity and specificity of anti-rabphilin-3A antibody testing in cases where histological diagnosis has been made.
  • 藤沢 治樹, 椙村 益久
    診断と治療 111(3) 315-321 2023年3月  
    <文献概要>Headline 1 血清ナトリウム濃度の異常は水バランスの異常である.2 低ナトリウム血症は細胞外液量に基づいて鑑別診断を進める.3 低ナトリウム血症の治療時はその補正速度に注意する.4高ナトリウム血症の原因の多くは脱水(自由水の欠乏)である.
  • 岩井 京子, 淺田 陽平, 森川 理佐, 藤沢 治樹, 平塚 いづみ, 植田 佐保子, 垣田 彩子, 四馬田 恵, 清野 祐介, 高柳 武志, 鈴木 敦詞
    日本内分泌学会雑誌 98(4) 994-994 2023年2月  
  • 高橋 明広, 古澤 翔, 亀田 啓, 宮 愛香, 野本 博司, 曹 圭龍, 中村 昭伸, 三好 秀明, 渥美 達也, 岩田 尚子, 藤沢 治樹, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 98(2) 564-564 2022年10月  
  • 佐久間 純, 山下 裕美子, 斎藤 聡, 斎藤 大祐, 菅家 さやか, 友常 健, 関 史子, 飯田 俊彦, 藤沢 治樹, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 98(2) 560-560 2022年10月  
  • 中山 将吾, 真柄 伸彦, 岡本 慧子, 岩田 尚子, 藤沢 治樹, 椙村 益久
    日本内分泌学会雑誌 98(2) 567-567 2022年10月  
  • 金子 正儀, 間島 貴之, 丹野 貴文, 徳永 帆南, 山口 遵, 上原 優斗, 廣瀬 慎司, 阿部 花奈子, 藤沢 治樹, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 98(2) 569-569 2022年10月  
  • 藤沢 治樹, 椙村 益久
    糖尿病・内分泌代謝科 55(3) 379-384 2022年9月  
  • Kazutaka Morota, Hiroaki Tadokoro, Kentaro Sawano, Kenichi Watanabe, Naoko Iwata, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura, Keisuke Nagasaki
    Journal of pediatric endocrinology & metabolism : JPEM 35(5) 687-690 2022年5月25日  
    OBJECTIVES: A highly invasive pathological diagnosis is necessary to differentiate central diabetes insipidus (CDI) with a thickened pituitary stalk. Lymphocytic infundibulo-hypophysitis (LIH) due to autoimmune involvement of the pituitary stalk is a differentiating disease, and anti-rabphilin-3A antibody (Rab3A-Ab) positivity was recently reported. CASE PRESENTATION: A 7-year-old boy was diagnosed with CDI after having polyuria for two months. He showed growth hormone deficiency with reduced growth rate. Brain magnetic resonance imaging (MRI) revealed a thickened pituitary stalk. The placental alkaline phosphatase level of the cerebrospinal fluid, tumor marker for germ cell tumors, was below the level of sensitivity. No skin or bone findings suggestive of Langerhans cell histiocytosis were detected. Eight months after CDI onset, Rab3A-Ab was positive, and MRI showed shrinking of the thickened pituitary stalk, leading to the diagnosis with LIH. CONCLUSIONS: Rab3A-Ab is a useful adjunctive diagnostic tool for childhood-onset LIH.
  • Yuka Takahashi, Hiraku Kameda, Aika Miya, Hiroshi Nomoto, Kyu Yong Cho, Akinobu Nakamura, Hiroki Nishimura, Hirokazu Kimura, Masaru Suzuki, Satoshi Konno, Ai Shimizu, Yoshihiro Matsuno, Michinari Okamoto, Hiroaki Motegi, Naoko Iwata, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura, Hideaki Miyoshi, Tatsuya Atsumi
    Pituitary 25(2) 321-327 2022年4月  
    PURPOSE: To explore the clinical significance of anti-rabphillin-3A antibody for the differential diagnosis of lymphocytic panhypophysitis. METHODS AND RESULTS: A 58-year-old Japanese man developed uveitis of unknown cause in 2017. In 2019, he became aware of polyuria. In August 2020, he noticed transient diplopia and was diagnosed with right abducens nerve palsy. At the same time, he complained of fatigue and loss of appetite. Head magnetic resonance imaging demonstrated enlargement of the pituitary stalk and pituitary gland, corresponding to hypophysitis. Hormone stimulation tests showed blunted responses with respect to all anterior pituitary hormones. Central diabetes insipidus was diagnosed on the basis of a hypertonic saline loading test. Taking these findings together, a diagnosis of panhypopituitarism was made. Computed tomography showed enlargement of hilar lymph nodes. Biopsies of the hilar lymph nodes revealed non-caseating epithelioid cell granulomas that were consistent with sarcoidosis. Biopsy of the anterior pituitary revealed mild lymphocyte infiltration in the absence of IgG4-positive cells, non-caseating granulomas, or neoplasia. Western blotting revealed the presence of anti-rabphilin-3A antibody, supporting a diagnosis of lymphocytic panhypophysitis. Because the patient had no visual impairment or severe uveitis, we continued physiological hormone replacement therapy and topical steroid therapy for the uveitis. CONCLUSION: To the best of our knowledge, this is the first case of anti-rabphilin 3A antibody positive lymphocytic panhypophysitis comorbid with sarcoidosis, diagnosed by both pituitary and hilar lymph node biopsy. The utility of anti-rabphilin-3A antibody for the differential diagnosis of hypophysitis like this case should be clarified with further case studies.
  • Chisato Fujisawa, Hiroyuki Umegaki, Taiki Sugimoto, Chi Hsien Huang, Haruki Fujisawa, Yoshihisa Sugimura, Masafumi Kuzuya, Kenji Toba, Takashi Sakurai
    Experimental gerontology 163 111778-111778 2022年3月26日  
    OBJECTIVES: Frailty is a state of increased vulnerability to poor resolution of homeostasis after a stressor. We hypothesized that frail older adults would tend to have electrolyte imbalances because they should have many stressors together with fragile physiological systems. In this study, we aimed to determine whether older adults with higher Frailty Index scores have electrolyte imbalances and to establish which domains of the Frailty Index are correlated with electrolyte imbalances. DESIGN: A cross-sectional study. SETTING AND PARTICIPANTS: A total of 4204 older adults aged 70 years or over who visited the Japanese National Center for Geriatrics and Gerontology. METHODS: We calculated the 50-item Frailty Index with the following domains: comorbidities, cognitive function and mood, basic and instrumental activities of daily living, physical function, nutrition, and fall risks from physical weakness and comorbidities. Participants were categorized into four groups: a non-frail group (Frailty Index ≤0.2), mildly frail group (0.20 < Frailty Index ≤0.3), moderately frail group (0.3 < Frailty Index ≤0.4), and severely frail group (0.4 < Frailty Index). Their serum sodium, potassium, calcium, and phosphorus concentrations were measured. A multiple regression model was used to explore the relationship of electrolyte imbalances with the Frailty Index and to determine which frailty domains are correlated with electrolyte imbalances. RESULTS: Compared with the non-frail group, the mildly and moderately frail groups tended to have hypernatremia and hypophosphatemia, whereas the severely frail group tended to have dysnatremia, hypokalemia, and hypophosphatemia. The estimated odds ratios increased by 15%-52% for each electrolyte imbalance as the Frailty Index increased by 0.1. The Frailty Index domains of cognitive function, activities of daily living, and nutrition were correlated with more than three kinds of electrolyte imbalances, the domains of physical function and fall risks from physical weakness were correlated with three kinds of electrolyte imbalances, and the domains of comorbidities and fall risks from comorbidities were correlated with two kinds of electrolyte imbalances. CONCLUSIONS: Older adults with higher Frailty Index scores tend to have electrolyte imbalances.
  • Zenei Arihara, Kanako Sakurai, Satsuki Niitsuma, Ryota Sato, Shozo Yamada, Naoko Inoshita, Naoko Iwata, Haruki Fujisawa, Takashi Watanabe, Atsushi Suzuki, Kazuhiro Takahashi, Yoshihisa Sugimura
    Scientific reports 12(1) 4440-4440 2022年3月15日  
    Central diabetes insipidus (CDI) is a rare condition caused by various underlying diseases including inflammatory and autoimmune diseases, and neoplasms. Obtaining an accurate definitive diagnosis of the underlying cause of CDI is difficult. Recently, anti-rabphilin-3A antibodies were demonstrated to be a highly sensitive and specific marker of lymphocytic infundibuloneurohypophysitis (LINH). Here, we report a detailed case series, and evaluated the significance of anti-rabphilin-3A antibodies in differentiating the etiologies of CDI. A prospective analysis was conducted in 15 consecutive patients with CDI from 2013 to 2020 at a single referral center. Anti-rabphilin-3A antibodies were measured and the relationship between antibody positivity and the clinical/histopathological diagnoses was evaluated. Among 15 CDI patients, the positive anti-rabphilin-3A antibodies were found in 4 of 5 LINH cases, 3 of 4 lymphocytic panhypophysitis (LPH) cases, one of 2 sarcoidosis cases, and one intracranial germinoma case, respectively. Two Rathke cleft cyst cases and one craniopharyngioma case were negative. This is the first report of anti-rabphilin-3A antibodies positivity in CDI patients with biopsy-proven LPH. Measurement of anti-rabphilin-3A antibodies may be valuable for differentiating CDI etiologies.
  • 平塚 いづみ, 山田 宏哉, 伊藤 光泰, 藤沢 治樹, 四馬田 恵, 清野 祐介, 高柳 武志, 椙村 益久, 橋本 修二, 鈴木 敦詞
    日本内分泌学会雑誌 97(5) 1132-1132 2022年3月  
  • 植田 佐保子, 中島 優華, 松尾 悠志, 九鬼 伴樹, 淺田 陽平, 戸松 瑛介, 吉野 寧維, 平塚 いづみ, 藤沢 治樹, 垣田 彩子, 四馬田 恵, 清野 祐介, 高柳 武志, 牧野 真樹, 楯谷 一郎, 鈴木 敦詞
    日本内分泌学会雑誌 97(5) 1162-1162 2022年3月  
  • Shinji Ueno, Yusuke Seino, Shihomi Hidaka, Ryuya Maekawa, Yuko Takano, Michiyo Yamamoto, Mika Hori, Kana Yokota, Atsushi Masuda, Tatsuhito Himeno, Shin Tsunekawa, Hideki Kamiya, Jiro Nakamura, Hitoshi Kuwata, Haruki Fujisawa, Megumi Shibata, Takeshi Takayanagi, Yoshihisa Sugimura, Daisuke Yabe, Yoshitaka Hayashi, Atsushi Suzuki
    Nutrients 14(5) 2022年2月25日  
    (1) Background: Protein stimulates the secretion of glucagon (GCG), which can affect glucose metabolism. This study aimed to analyze the metabolic effect of a high-protein diet (HPD) in the presence or absence of proglucagon-derived peptides, including GCG and GLP-1. (2) Methods: The response to HPD feeding for 7 days was analyzed in mice deficient in proglucagon-derived peptides (GCGKO). (3) Results: In both control and GCGKO mice, food intake and body weight decreased with HPD and intestinal expression of Pepck increased. HPD also decreased plasma FGF21 levels, regardless of the presence of proglucagon-derived peptides. In control mice, HPD increased the hepatic expression of enzymes involved in amino acid metabolism without the elevation of plasma amino acid levels, except branched-chain amino acids. On the other hand, HPD-induced changes in the hepatic gene expression were attenuated in GCGKO mice, resulting in marked hyperaminoacidemia with lower blood glucose levels; the plasma concentration of glutamine exceeded that of glucose in HPD-fed GCGKO mice. (4) Conclusions: Increased plasma amino acid levels are a common feature in animal models with blocked GCG activity, and our results underscore that GCG plays essential roles in the homeostasis of amino acid metabolism in response to altered protein intake.
  • 藤沢 治樹, 椙村 益久
    糖尿病・内分泌代謝科 53(6) 616-620 2021年12月  
  • 西田 康貴, 吉野 寧維, 淺田 陽平, 田中 知香, 藤沢 治樹, 平塚 いづみ, 植田 佐保子, 垣田 彩子, 四馬田 恵, 清野 祐介, 高柳 武志, 鈴木 敦詞
    日本内分泌学会雑誌 97(4) 884-884 2021年12月  
  • 西田 康貴, 吉野 寧維, 淺田 陽平, 田中 知香, 藤沢 治樹, 平塚 いづみ, 植田 佐保子, 垣田 彩子, 四馬田 恵, 清野 祐介, 高柳 武志, 鈴木 敦詞
    日本内分泌学会雑誌 97(4) 884-884 2021年12月  
  • 中山 将吾, 藤沢 治樹, 根木 加奈, 松本 沙弓, 稲田 健一, 加藤 庸子, 椙村 益久
    日本内分泌学会雑誌 97(2) 506-506 2021年10月  
  • 高橋 由華, 亀田 啓, 曹 圭龍, 中村 昭伸, 西村 弘基, 木村 孔一, 清水 亜衣, 岡本 迪成, 茂木 洋晃, 岩田 尚子, 藤沢 治樹, 鈴木 敦詞, 椙村 益久, 三好 秀明, 渥美 達也
    日本内分泌学会雑誌 97(2) 495-495 2021年10月  
  • Yasutaka Tsujimoto, Tomoaki Nakamura, Jun Onishi, Naoto Ishimaru, Naoko Iwata, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura, Kazuo Chihara
    Internal medicine (Tokyo, Japan) 61(3) 365-371 2021年8月6日  
    A 21-year-old Japanese man without known diabetes mellitus had abdominal pain. The diagnosis was ketoacidosis and hypertriglyceridemia-induced acute pancreatitis. He had polydipsia and polyuria and had habitually drunk several soft drinks every day for two years. After hospitalization, despite adequate liquid intake, dehydration remained with hypotonic polyuria. Further examinations revealed the coexistence of central diabetes insipidus (CDI), possibly caused by lymphocytic infundibulo-neurohypophysitis, based on anti-rabphilin-3A antibody positivity. Although CDI had been undiagnosed for two years, over-consumption of sugar-rich soft drinks to ease thirst caused ketoacidosis, hypertriglyceridemia, and acute pancreatitis. There are no previous reports of this three-part combination of symptoms caused by CDI.
  • 上野 慎士, 清野 祐介, 増田 富, 酒井 志保美, 村瀬 正敏, 藤沢 治樹, 平塚 いづみ, 四馬田 恵, 高柳 武志, 椙村 益久, 林 良敬, 鈴木 敦詞
    糖尿病 64(Suppl.1) I-5 2021年5月  
  • 西田 康貴, 高柳 武志, 中島 優華, 山口 健介, 淺田 陽平, 上野 慎士, 松尾 悠志, 藤沢 治樹, 吉野 寧維, 平塚 いづみ, 植田 佐保子, 垣田 彩子, 四馬田 恵, 清野 祐介, 鈴木 敦詞
    糖尿病 64(Suppl.1) I-7 2021年5月  
  • 轟木 秀親, 高柳 武志, 田中 知香, 森川 理佐, 藤沢 治樹, 牧野 真樹, 清野 祐介, 鈴木 敦詞
    糖尿病 64(Suppl.1) P-1 2021年5月  
  • 藤沢 治樹, 中山 将吾, 川上 司, 上野 慎士, 淺田 陽平, 戸松 瑛介, 吉野 寧維, 平塚 いづみ, 清野 祐介, 四馬田 恵, 高柳 武志, 椙村 益久, 鈴木 敦詞
    日本内分泌学会雑誌 97(1) 261-261 2021年4月  
  • 西田 康貴, 清野 祐介, 松尾 悠志, 前川 龍也, 藤沢 治樹, 平塚 いづみ, 植田 佐保子, 垣田 彩子, 四馬田 恵, 高柳 武志, 鈴木 敦詞
    糖尿病 64(2) 134-134 2021年2月  
  • Chisato Fujisawa, Hiroyuki Umegaki, Taiki Sugimoto, Satoshi Samizo, Chi Hsien Huang, Haruki Fujisawa, Yoshihisa Sugimura, Masafumi Kuzuya, Kenji Toba, Takashi Sakurai
    BMC geriatrics 21(1) 15-15 2021年1月6日  
    BACKGROUND: Mild hyponatremia (serum sodium 130-135 mEq/L) is a common electrolyte disorder in the elderly. However, its association with both sarcopenia and cognitive function remains to be clarified. Therefore, here we investigated the association of mild hyponatremia with skeletal muscle mass, physical function, and cognitive function in the elderly. METHODS: We enrolled 75 participants with mild hyponatremia and 2907 with normonatremia (serum sodium, 136-145 mEq/L) aged ≥70 years who visited the Memory Disorder Outpatient Center of Japan's National Center for Geriatrics and Gerontology. Skeletal muscle mass index (SMI), grip strength (GS), walking speed (WS), one-leg standing (OLS) test times, and neuropsychological test scores were determined. RESULTS: One-way analysis of covariance showed that elderly participants with mild hyponatremia had lower SMI (7.1 ± 0.2, 7.2 ± 0.2 kg/m2, p = 0.04), weaker GS (19.1 ± 1.9 vs 21.4 ± 1.8 kg, p = 0.01), slower WS (0.9 ± 0.1 vs 1.1 ± 0.1 m/s, p = 0.001), and higher GDS- 15 score (6.4 ± 0.9 vs 5.2 ± 0.9, p = 0.002) than those with normonatremia. Multiple logistic regression analysis indicated that mild hyponatremia was independently associated with sarcopenia (odds ratio [OR]: 2.2, p = 0.02), slower WS (OR: 5.3, p = 0.04) and shorter OLS time (OR: 2.5, p = 0.02) as well as with severe depressive mood (OR: 2.6 p = 0.006) but not with SMI (OR: 1.6, p = 0.2) or GS (OR: 1.9, p = 0.09). CONCLUSIONS: Our results suggest that elderly people with even mild hyponatremia had physical function impairment and depressive mood.
  • 中島 優華, 生田 麻美, 戸松 瑛介, 上野 慎士, 吉野 寧維, 平塚 いづみ, 藤沢 治樹, 植田 佐保子, 清野 祐介, 高柳 武志, 鈴木 敦詞
    日本内分泌学会雑誌 96(3) 719-719 2021年1月  
  • 藤沢 治樹, 椙村 益久
    糖尿病・内分泌代謝科 51(6) 473-476 2020年12月  
  • 樋口 雄一, 井出 陽子, 田邉 万璃子, 笠松 大悟, 本村 悠馬, 岡田 武大, 辻村 英二, 原田 貴成, 下田平 眞生子, 沼 眞喜子, 北野 則和, 中村 嘉夫, 藤沢 治樹, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 96(2) 498-498 2020年10月  
  • 岡崎 玲, 南 勲, 長瀬 恵美, 三好 泰斗, 王 新, 足立 由布子, 藤沢 治樹, 椙村 益久, 鈴木 敦詞, 太田 一樹, 渡辺 孝之
    日本内分泌学会雑誌 96(2) 499-499 2020年10月  
  • 中山 将吾, 藤沢 治樹, 田中 知香, 渡邉 督, 稲田 健一, 加藤 庸子, 椙村 益久
    日本内分泌学会雑誌 96(2) 501-501 2020年10月  
  • 安井 彩乃, 亀田 啓, 宮 愛香, 野本 博司, 曹 圭龍, 中村 昭伸, 茂木 洋晃, 藤沢 治樹, 鈴木 敦詞, 三好 秀明, 椙村 益久, 渥美 達也
    日本内分泌学会雑誌 96(2) 556-556 2020年10月  
  • 植田 佐保子, 森川 理佐, 公文 尚子, 良元 亮, 藤沢 治樹, 平塚 いづみ, 垣田 彩子, 四馬田 恵, 清野 祐介, 高柳 武志, 牧野 真樹, 鈴木 敦詞
    日本内分泌学会雑誌 96(2) 539-539 2020年10月  
  • Tetsuro Niri, Ichiro Horie, Hiromi Kawahara, Takao Ando, Noriaki Fukuhara, Hiroshi Nishioka, Naoko Inoshita, Haruki Fujisawa, Atsushi Suzuki, Yoshihisa Sugimura, Norio Abiru, Atsushi Kawakami
    Endocrine journal 68(1) 119-127 2020年9月19日  
    Idiopathic hypothalamitis is a rare condition that can cause anterior pituitary dysfunction and central diabetes insipidus (CDI), occasionally accompanied by a disturbance of autonomic regulation known as hypothalamic syndrome. This condition has been described as a subtype of autoimmune (lymphocytic) hypophysitis; however, some cases of isolated hypothalamic involvement with no inflammatory lesions in either the pituitary gland or infundibulum have been reported. The detailed epidemiology and pathophysiology of isolated hypothalamitis have not been clarified. We herein report a case of a solitary hypothalamic lesion in a young woman who showed spontaneous development of CDI and panhypopituitarism accompanied by hyperphagia. The hypothalamic lesion increased from 11 × 7 to 17 × 7 mm over 16 months based on the sagittal slices of magnetic resonance imaging examinations. The negative results for anti-pituitary antibodies and anti-Rabphilin-3A antibodies suggested that upward extension of lymphocytic adenohypophysitis or infundibulo-neurohypophysitis was unlikely. Infectious disease, granulomatosis, Langerhans cell histiocytosis, vasculitis, and systemic neoplastic diseases were excluded by the findings of a laboratory investigation, cerebrospinal fluid examination, and imaging studies. To make a definitive diagnosis, we performed a ventriculoscopic biopsy of the hypothalamic lesion. Histology revealed an infiltration of nonspecific lymphoplasmacytes with no evidence of neoplasm, which was consistent with a diagnosis of idiopathic hypothalamitis. Subsequently, the patient was treated with methylprednisolone pulse therapy followed by oral prednisolone. The hypothalamic lesion improved and remained undetectable after withdrawal of the prednisolone, suggesting that the glucocorticoid treatment was effective for isolated hypothalamitis while the patient remains dependent on the replacement of multiple hormones.
  • Tsukasa Kawakami, Haruki Fujisawa, Shogo Nakayama, Yasumasa Yoshino, Satoko Hattori, Yusuke Seino, Takeshi Takayanagi, Tsuyoshi Miyakawa, Atsushi Suzuki, Yoshihisa Sugimura
    Endocrine journal 68(1) 31-43 2020年9月2日  査読有り
    Recently, chronic hyponatremia, even mild, has shown to be associated with poor quality of life and high mortality. The mechanism by which hyponatremia contributes to those symptoms, however, remains to be elucidated. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is a primary cause of hyponatremia. Appropriate animal models are crucial for investigating the pathophysiology of SIADH. A rat model of SIADH has been generally used and mouse models have been rarely used. In this study, we developed a mouse model of chronic SIADH in which stable and sustained hyponatremia occurred after 3-week continuous infusion of the vasopressin V2 receptor agonist 1-desamino-8-D-arginine vasopressin (dDAVP) and liquid diet feeding to produce chronic water loading. Weight gain in chronic SIADH mice at week 2 and 3 after starting dDAVP injection was similar to that of control mice, suggesting that the animals adapted to chronic hyponatremia and grew up normally. AQP2 expression in the kidney, which reflects the renal action of vasopressin, was decreased in dDAVP-infused water-loaded mice as compared with control mice that received the same dDAVP infusion but were fed pelleted chow. These results suggest that "vasopressin escape" occurred, which is an important process for limiting potentially fatal severe hyponatremia. Behavioral analyses using the contextual and cued fear conditioning test and T-maze test demonstrated cognitive impairment, especially working memory impairment, in chronic SIADH mice, which was partially restored after correcting hyponatremia. Our results suggest that vasopressin escape occurred in chronic SIADH mice and that chronic hyponatremia contributed to their memory impairment.
  • 在原 善英, 桜井 華奈子, 新妻 さつき, 佐藤 良太, 山田 正三, 井下 尚子, 藤沢 治樹, 鈴木 敦詞, 椙村 益久
    日本内分泌学会雑誌 96(1) 238-238 2020年8月  
  • 菱田 藍, 江端 千尋, 池田 達也, 福田 真紀, 鈴木 敦詞, 藤沢 治樹, 岩田 純, 椙村 益久, 菅野 尚
    日本内分泌学会雑誌 96(1) 363-363 2020年8月  
  • 川上 司, 藤沢 治樹, 中山 将吾, 淺田 陽平, 増田 富, 戸松 瑛介, 吉野 寧維, 平塚 いづみ, 清野 祐介, 四馬田 恵, 高柳 武志, 椙村 益久, 鈴木 敦詞
    日本内分泌学会雑誌 96(1) 271-271 2020年8月  
  • 轟木 秀親, 高柳 武志, 藤沢 治樹, 平塚 いづみ, 植田 佐保子, 垣田 彩子, 四馬田 恵, 清野 祐介, 牧野 真樹, 早川 伸樹, 鈴木 敦詞
    糖尿病 63(Suppl.1) S-301 2020年8月  
  • Haruki Fujisawa, Manassawee Korwutthikulrangsri, Jiao Fu, Xiao-Hui Liao, Alexandra M Dumitrescu
    Endocrinology 161(5) 2020年5月1日  査読有り
    Selenocysteine insertion sequence-binding protein 2, SBP2 (SECISBP2), is required for selenoprotein synthesis. Partial SBP2 deficiency syndrome manifests characteristic thyroid function tests. The Sbp2 deficiency mouse model, Sbp2 inducible conditional knockout (iCKO), replicates this thyroid phenotype and was used for pathophysiologic investigations. As selenoproteins have an antioxidative role in thyroid gland function, their deficiencies have potential to affect thyroid hormone (TH) synthesis. Sbp2 iCKO mice had larger thyroids relative to body weight and increased thyroidal thyroxine (T4) and triiodothyronine (T3) content while 5' deiodinases enzymatic activities were decreased. Possible mechanisms for the discrepancy between the increased thyroidal T3 and normal circulating T3 were investigated in dynamic experiments. Treatment with bovine thyroid-stimulating hormone (TSH) resulted in increased delta T4 in Sbp2 iCKO mice, indicating increased availability of preformed thyroidal TH. Next, the recovery of TH levels was evaluated after withdrawal of chemical suppression. At one day, Sbp2 iCKO mice had higher serum and thyroidal T3 concomitant with lower TSH, confirming increased capacity of TH synthesis in Sbp2 deficiency. Decreased TH secretion was ruled out as serum and thyroidal TH were high in Sbp2 iCKO mice. Treatment with a low-iodine diet also ruled out thyroidal secretion defect as both serum levels and thyroidal TH content similarly declined over time in Sbp2-deficient mice compared to wild-type (Wt) mice. This study provides evidence for unsuspected changes in the thyroid gland that contribute to the thyroid phenotype of Sbp2 deficiency, with increased thyroidal T4 and T3 content in the setting of increased TH synthesis capacity contributing to the circulating TH levels while thyroidal secretion is preserved.

MISC

 64

書籍等出版物

 1

共同研究・競争的資金等の研究課題

 9